Literature DB >> 23547071

Evolving panorama of treatment for metastatic pancreas adenocarcinoma.

Eileen M O'Reilly.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23547071     DOI： 10.1200/JCO.2013.48.7660

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

Review 1.  Is it time to split strategies to treat homologous recombinant deficiency in pancreas cancer?

Authors:  Min Yuen Teo; Eileen M O'Reilly
Journal:  J Gastrointest Oncol       Date:  2016-10

Review 2.  Perspectives in the treatment of pancreatic adenocarcinoma.

Authors:  Angel Cid-Arregui; Victoria Juarez
Journal:  World J Gastroenterol       Date:  2015-08-21       Impact factor: 5.742

Review 3.  Pharmacotherapeutic Management of Pancreatic Ductal Adenocarcinoma: Current and Emerging Concepts.

Authors:  Dietrich A Ruess; Kivanc Görgülü; Sonja M Wörmann; Hana Algül
Journal:  Drugs Aging       Date:  2017-05       Impact factor: 4.271

4.  Health-related quality of life in a randomised phase III study of gemcitabine plus S-1, S-1 alone and gemcitabine alone for locally advanced or metastatic pancreatic cancer: GEST study.

Authors:  Yasuhiro Hagiwara; Yasuo Ohashi; Takuji Okusaka; Hideki Ueno; Tatsuya Ioka; Narikazu Boku; Shinichi Egawa; Takashi Hatori; Junji Furuse; Kazuhiro Mizumoto; Shinichi Ohkawa; Taketo Yamaguchi; Kenji Yamao; Akihiro Funakoshi; Ann-Lii Cheng; Kiyohiro Kihara; Atsushi Sato; Masao Tanaka
Journal:  ESMO Open       Date:  2017-03-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.